Industry News 23 Oct 2026

Press Release: Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile

Source: Finanzen •By dow jones •1 min read

-- Remibrutinib achieved significant and clinically meaningful reduction in relapses vs. teriflunomide, to approximately 1 relapse every 13 years, without the need for chronic B-cell depletion(1) (2) -- MRI disease activity significantly reduced with remibrutinib vs. teriflunomide in two trials, including...

This is a short summary. The full story is published by Finanzen.

Read full story at Finanzen
#phase iii

Related news

Industry News
Novartis Pharma AG: Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with…

Remibrutinib achieved significant and clinically meaningful reduction in relapses vs. teriflunomide, to approximately 1 relapse every 13 years…

Finanznachrichten.de• 23 Oct 2026 •1 min read
#control#delivered#novartis
Read story
Industry News
Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety…

Basel, October 23, 2026 – Novartis today presented positive results from the pivotal Phase III REMODEL-1 and REMODEL-2 trials in relapsing multiple…

Globenewswire_fr• 23 Oct 2026 •1 min read
#2890#ch0012005267#company announcement
Read story
Industry News
Small Cell Lung Cancer Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and Route of…
Abnewswire• 23 Oct 2026
#diseases#phase ii#phase iii
Read story
Industry News
FDA approves Roche’s Enspryng as first at-home injection treatment for thyroid eye disease

The approval was supported by data from Roche’s pivotal Phase III SatraGO programme

Indianpharmapost• 19 Oct 2026 •1 min read
#enspryng#fda approves#phase iii
Read story
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Trending tags
#pharma #pharmaceutical #fda approval #diseases #pharmaceuticals #clinical trial #fda approves #pharma and healthcare #biosimilar #phase iii #science and innovations #research #vaccine #drug #world news
Browse by category
Industry News 89 Regulatory 5
Top sources
A Abnewswire 10 stories
I Indianpharmapost 5 stories
F Finanznachrichten.de 5 stories
K Kalkine Media 4 stories
F FDA 4 stories
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit